Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease eosinophilia
Phenotype |rash
Sentences 147
PubMedID- 25303297 Aim: salazosulfapyridine (sasp) frequently causes several adverse reactions, such as drug rash with eosinophilia and systemic symptoms (dress).
PubMedID- 23455629 No cases of hypersensitivity reactions, such as drug rash with eosinophilia and systemic symptoms (dress), steven-johnson syndrome, or toxic epidermal necrolysis, were reported.
PubMedID- 22162933 Allopurinol causing drug rash with eosinophilia and systemic symptoms syndrome: a challenging diagnosis.
PubMedID- 24600147 Toxic epidermal necrolysis, erythroderma, drug rash with eosinophilia and systemic symptoms, acute generalised exanthematous pustulosis and drug induced vasculitis are the common cutaneous drug reactions which can have severe morbidity and even mortality.
PubMedID- 20945612 Drug-related rash with eosinophilia and systemic symptoms (dress) syndrome, or drug-induced hypersensitivity syndrome (dihs), is a life-threatening multiorgan systemic reaction characterized by rash, fever, lymphadenopathy, hepatitis, and leukocytosis with eosinophilia.
PubMedID- 22744268 Cases of urticaria, angioedema, anaphylaxis, cytopenia, vasculitis, acute allergic interstitial nephritis, occupational contact dermatitis, photoallergic dermatitis, maculopapular eruption, erythroderma, drug rash with eosinophilia and systemic symptoms (dress) syndrome, stevens-johnson syndrome/toxic epidermal necrolysis, and other autoimmune reactions (including cutaneous lupus erythematosus) have been described.
PubMedID- 20546480 Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine.
PubMedID- 20627444 [oxcarbazepine drug rash with eosinophilia and systemic symptoms (dress) syndrome mimicking septic shock].
PubMedID- 22052666 Hhv-6b reactivation often occurs in immunocompetent individuals during drug induced hypersensitivity syndrome (dihs) and the related drug rash with eosinophilia and systemic symptoms (dress).
PubMedID- 20861604 The hhv-7 reactivation might be related to facial pustulosis, which is occasionally observed in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms.
PubMedID- 23616701 Modafinil has been linked to development of stevensjohnson syndrome, toxic epidermal necrolysis, and drug rash with eosinophilia and systemic symptoms (dress) and there is no reason to suspect that the same problem would not be caused by armodafinil.
PubMedID- 24333861 We report a case of drug rash with eosinophilia and systemic symptoms (dress) due to boceprevir.
PubMedID- 22224160 Drug rash with eosinophilia and systemic symptoms: two emergency department cases.
PubMedID- 21947692 Drug-related rash with eosinophilia and systemic symptoms (dress) or drug-induced hypersensitivity syndrome (dihs) is a life-threatening multiorgan systemic reaction characterized by rash, fever, lymphadenopathy, hepatitis, and leukocytosis with eosinophilia [1].
PubMedID- 26399967 We diagnosed scars using code 695.1 in both icd-9 (international classification of diseases, 9th revision) and icd-9-cm (clinical modification), which are commonly used in studies of adverse drug reactions.2627 the icd-9-cm 695.1 code covers all scars, including drug rash with eosinophilia and systemic symptoms, stevens-johnson syndrome, and toxic epidermal necrolysis.
PubMedID- 22937315 "drug rash with eosinophilia and systemic symptoms" (dresss) syndrome describes a potentially serious multiorgan inflammatory response to certain classes of drugs; this includes the use of ace inhibitors.
PubMedID- 26281488 Skin biopsy revealed interface dermatitis, suggesting the diagnosis of dress (drug rash with eosinophilia and systemic symptoms) syndrome.
PubMedID- 26351424 Drug-induced hypersensitivity syndrome (dihs), also called drug rash with eosinophilia and systemic symptoms (dress), is a severe multiorgan system adverse drug reaction characterized by skin eruption, fever, lymph node swelling, liver dysfunction and eosinophilia.
PubMedID- 26519419 We report the first case of drug rash with eosinophilia and systemic symptoms (dress) following strontium ranelate (sr) treatment associated with systemic human hhv-7 reactivation.
PubMedID- 25986261 Isoniazid-induced drug rash with eosinophilia and systemic symptoms (dress) syndrome presenting as acute eosinophilic myocarditis.
PubMedID- 25114941 Ceftriaxone induced drug rash with eosinophilia and systemic symptoms.
PubMedID- 25749785 Furthermore, no cases of sorafenib-induced severe cutaneous adverse reactions (scars), such as sjs, toxic epidermal necrolysis, or drug rash with eosinophilia and systemic symptoms (dress), have been reported yet.
PubMedID- 22901319 Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
PubMedID- 26238129 Drug rash with eosinophilia and systemic symptoms (dress syndrome) in a severe cutaneous drug reaction, which can be life threatening.
PubMedID- 21072291 During post–marketing surveillance, isolated cases of hypersensitivity syndrome or drug rash with eosinophilia and systemic symptoms have been reported.
PubMedID- 20358021 Similar to patch tests, ltt are often positive in mpe, bullous exanthema, agep, and drug rash with eosinophilia and systemic symptoms (dress).
PubMedID- 26509009 Drug rash with eosinophilia and systemic symptoms (dress), also named drug-induced hypersensitivity syndrome (dihs) is a serious multiorgan disease, which is caused by a drug-induced specific immune reaction.
PubMedID- 26120548 A case of drug rash with eosinophilia and systemic symptoms (dress) syndrome under cilostazol and carbamazepine treatment has been published; dress resolved following discontinuation of both drugs and could be reproduced by challenge tests with the individual substances at a 4-week interval.
PubMedID- 26484021 Other adverse effects reported include anaphylaxis [1], vasculitis, ototoxicity, fixed drug eruptions, fever, phlebitis, nephrotoxicity, interstitial nephritis, agranulocytosis, thrombocytopenia, linear immunoglobulin (ig)a bullous dermatosis, toxic epidermal necrolysis, and more rarely stevens–johnson [2], or drug rash with eosinophilia and systemic symptoms syndrome.
PubMedID- 25234569 Drug rash with eosinophilia and systemic symptoms is a drug hypersensitivity reaction.
PubMedID- 20485160 Summary: for certain drug eruptions mediated by t cells (exanthemata, acute generalized exanthematous pustulosis, drug rash with eosinophilia and systemic symptoms, erythema multiforme/toxic epidermal necrolysis, fixed drug eruption and symmetrical drug-related intertriginous and flexural exanthem) patch tests can elicit positive responses in a proportion of cases.
PubMedID- 20456395 Anticonvulsants) have been implicated in the development of two distinct forms of severe cutaneous drug reactions, stevens-johnson syndrome (sjs)/toxic epidermal necrolysis (ten) and drug-induced hypersensitivity syndrome (dihs)/drug rash with eosinophilia and systemic symptoms (dress).
PubMedID- 24450829 Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man.
PubMedID- 21702250 Penicillin v-induced drug rash with eosinophilia and systemic symptoms.
PubMedID- 21098750 First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.
PubMedID- 23456403 Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbital.
PubMedID- 25239077 A case of drug rash with eosinophilia and systemic symptoms (dress) induced by telaprevir associated with hhv-6 active infection.
PubMedID- 23541141 Introduction: drug rash with eosinophilia and systemic symptoms (dress) syndrome is a drug-induced hypersensitivity syndrome, characterized by rash, hyereosinophilia and multiorgan failure, including cytolytic hepatitis.
PubMedID- 26416594 Such reactions can manifest as a rash combined with eosinophilia, leukocytosis, fever, hepatitis and progressive kidney failure.
PubMedID- 20688003 Anticonvulsant hypersensitivity syndrome, or dress (drug rash with eosinophilia and systemic symptoms), is a rare multisystem disorder, potentially fatal, that occurs after exposure to antiepileptic drugs, mainly aromatic ones.
PubMedID- 21576578 In toxic epidermal necrolysis/stevens-johnson syndrome and drug rash with eosinophilia and systemic symptoms, the number of apoptotic endothelial cells was related to the extension of skin lesions and the presence of purpura.
PubMedID- 24021364 Drug rash (or reaction) with eosinophilia and systemic symptoms (dress) is a potentially life-threatening hypersensitivity reaction to drugs characterized by rash, fever, lymphadenopathy, hematologic abnormalities, and involvement of internal organs.
PubMedID- 23829691 Drug rash with eosinophilia and systemic symptoms (dress) syndrome and hepatitis induced by phenytoin.
PubMedID- 23361875 Drug rash with eosinophilia and systemic symptoms (dress) in patients receiving strontium ranelate.
PubMedID- 20666193 Drug rash with eosinophilia and systemic symptoms (dress) syndrome, toxic epidermal necrolysis (ten), and stevens-johnson syndrome (sjs) are rare and life-threatening conditions that may be precipitated by anticonvulsive agents.
PubMedID- 20831538 Dress-syndrome (drug rash with eosinophilia and systemic symptoms) is a severe drug-induced hypersensitivity syndrome characterized by diffuse maculopapular rash, lymphadenopathy, multivisceral involvement, eosinophilia and atypical lymphocytes with a mortality rate of 10-40% (seminars in cutaneous medicine and surgery, 1, 250).
PubMedID- 21998830 Case of drug rash with eosinophilia and systemic symptoms induced by zonisamide and reactivation of human herpes virus 7.
PubMedID- 24635062 Background: drug-induced hypersensitivity syndrome/drug rash with eosinophilia with systemic symptoms (dihs/dress) is a severe drug eruption accompanied by multiorgan disorders.
PubMedID- 24599767 Methods: we retrospectively analyzed 74 cases of scars, including stevens-johnson syndrome (sjs), toxic epidermal necrolysis (ten), drug rash with eosinophilia and systemic symptoms (dress), and acute generalized exanthematous pustulosis (agep), related to use of systemic antibiotics in taiwan from january 2006 to january 2012.
PubMedID- 22712013 The principal differential diagnoses of agep consist of pustular psoriasis, sweet's syndrome, pustular erythema multiforme, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms, subcorneal pustulosis (sneddon-wilkinson syndrome), pustular vasculitis, and bullous impetigo [9, 10, 11].

Page: 1 2 3